Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1831 clinical trials
Therapeutic Adherence in Uncontrolled Arterial Hypertension

The determination of antihypertensive drugs or their metabolites in urine seems to be a good indicator of therapeutic adherence. On the other hand, the implementation of a specific program to improve knowledge of the disease and its risks and promote therapeutic adherence could improve the control of hypertension and reduce …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)

Funding to progress to Phase 2 of this trial has been obtained. It is anticipated 120 subjects participating in Phase 1 will be screened for eligibility for Phase 2 (separate consent and eligibility from Phase 1).

cancer treatment
lumpectomy
invasive breast cancer
lymphedema
mastectomy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Taking Open Label Placebo Further: Trial of Imaginary Pills in Test Anxiety

Interventions (seven to three weeks before the exam) will be held online using a video Chat application such as zoom (https://zoom.us/) or skype (https://www.skype.com/de/) or will take place at the division of Clinical Psychology and Psychotherapy, University of Basel (Missionsstrasse 62, 4055 Basel).

  • 0 views
  • 16 Feb, 2024
  • 1 location
Comparison of Extended Totally Extra-peritoneal Repair (ETEP) and Subcutaneous On-lay Endoscopic Approach (SCOLA) for Para-umbilical Hernia (PUH).

Researchers will compare the ETEP repair group to the SCOLA repair group to see if one method leads to better outcomes for patients.Participants will:Be randomly assigned to receive either the ETEP or SCOLA surgical repair.Have their surgery and recovery tracked by the research team.

  • 0 views
  • 27 Feb, 2026
Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

Due to the lack of evidence for an optimal radiotherapy regimen for an "in-situ vaccination" effect three different radiotherapy regimens will be tested.

pet/ct scan
neutrophil count
complete excision
immunomodulators
stage iii non-small cell lung cancer
  • 0 views
  • 16 Feb, 2024
  • 13 locations
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag

They will visit NIH every 6 months and repeat the above tests. Participants will be monitored for up to 3 years after they stop taking eltrombopag. They will visit NIH 6 months after treatment ends. If participants blood counts go down after treatment ends, they may restart the drug....

corticosteroids
anemia
bone marrow biopsy
bone marrow erythroid
eltrombopag
  • 0 views
  • 16 Feb, 2024
  • 1 location
The Effects of Low Dose Ketamine on Cardiovascular Function

Prior studies on low dose ketamine have noted short-term (minutes to hours) increases or decreases in blood pressure. Blood pressure that is too high or too low can be problematic if untreated. It is unknown exactly how low dose ketamine affects blood pressure. In fact, no prior studies have measured …

anxiety
diastolic blood pressure
ketamine
depression
nervous system
  • 0 views
  • 16 Feb, 2024
  • 1 location
Clinical Feasibility of Minimally Supervised Therapy After Stroke With a Hand Rehabilitation Robot

Minimally supervised therapy means that after a training phase, where the therapists teach to the patients how to perform the exercises with the robot, the patients can autonomously train with the robot during free time without being directly supervised. Our hypothesis is that minimally supervised therapy might be a possible …

ataxia
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Part 3 and Part 4: Participants aged 6 < 12 will receive risankizumab based on body weight. Around 132 participants will be enrolled in approximately 30 sites worldwide. Risankizumab and ustekinumab are given as a subcutaneous (under the skin) injection.

pediatric
ustekinumab
blood tests
systemic therapy
risankizumab
  • 0 views
  • 05 Aug, 2020
Diffusion MRI for Head and Neck Cancer

Previous studies have shown that both diffusion coefficient D and diffusional kurtosis coefficient K are promising imaging markers of (i) cell viability which can be used for evaluation of early treatment response. However, it is often underappreciated that these dMRI metrics are not fixed constants, but rather functions of the …

  • 0 views
  • 25 Apr, 2025